03933.HK
The United Laboratories International Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 6.83
−0.36%Year over year
Reported trailing growth
- Revenue
- -15.9%
- EBITDA
- -67.7%
- EBIT
- -83.5%
- EPS
- -83.4%
- Free cash flow
- -69.8%
- Operating cash flow
- -48.2%
Forward estimates
Based on analyst estimates
- Revenue
- -47.1%
- EBITDA
- -26.3%
- EPS
- -28.2%
Three-year CAGR
- Revenue
- +5.2%
- EBITDA
- +3.8%
- EBIT
- +4.1%
- Net income
- +9.7%
- EPS
- +8.5%
- Free cash flow
- -11.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026